Stock Earnings

Question 1

What are Century Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Century Therapeutics Inc has a total asset of $353, Net loss of $-126

Question 2

What are the key financial ratios for IPSC?

Accepted Answer

Century Therapeutics Inc's Current ratio is 1.84, has a Net margin is -2,100, sales per share of $0.07.

Question 3

How is Century Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Century Therapeutics Inc largest revenue segment is Allogeneic Cell Therapies, at a revenue of 6,589,000 in the most earnings release.For geography, United States is the primary market for Century Therapeutics Inc, at a revenue of 6,589,000.

Question 4

Is Century Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Century Therapeutics Inc has a net loss of $-126

Question 5

Does Century Therapeutics Inc have any liabilities?

Accepted Answer

yes, Century Therapeutics Inc has liability of 191

Question 6

How many outstanding shares for Century Therapeutics Inc?

Accepted Answer

Century Therapeutics Inc has a total outstanding shares of 85.83

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	113	6	2	5	0	0
Revenue Growth (YoY)	5,550%	200%	-60%	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	30	33	34	31	19	9
Research & Development	105	107	92	97	75	39
Operating Expenses	136	140	127	129	94	49
Other Non Operating Income (Expenses)	0	0	0	4	0	0
Pretax Income	-24	-124	-134	-130	-95	-53
Income Tax Expense	1	1	1	0	0	--
Net Income	-26	-126	-136	-130	-95	-53
Net Income Growth	-80%	-7%	5%	37%	79%	-78%
Shares Outstanding (Diluted)	86.46	78.64	59.31	57.76	32.39	7.48
Shares Change (YoY)	2%	33%	3%	78%	333%	1%
EPS (Diluted)	-0.3	-1.6	-2.3	-2.27	-2.96	-7.16
EPS Growth	-80%	-30%	2%	-23%	-59%	-78%
Free Cash Flow	-113	-110	-102	-16	-133	-55
Free Cash Flow Per Share	-1.3	-1.39	-1.71	-0.27	-4.1	-7.35
Gross Margin	--	--	--	--	--	--
Operating Margin	-19.46%	-2,216.66%	-6,250%	-2,460%	0%	0%
Profit Margin	-23%	-2,100%	-6,800%	-2,600%	0%	0%
Free Cash Flow Margin	-100%	-1,833.33%	-5,100%	-320%	0%	0%
EBITDA	-10	-120	-112	-115	-91	-48
EBITDA Margin	-8.84%	-2,000%	-5,600%	-2,300%	0%	0%
D&A For EBITDA	12	13	13	8	3	1
EBIT	-22	-133	-125	-123	-94	-49
EBIT Margin	-19.46%	-2,216.66%	-6,250%	-2,460%	0%	0%
Effective Tax Rate	-4.16%	-0.8%	-0.74%	0%	0%	--

Century Therapeutics Inc (IPSC) Price

IPSC Stock Price Chart

IPSC Income

Follow-Up Questions